|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07J 7/00 | (2006.01) |
| C07J 1/0029 | (2013.01) | ||
| C07J 17/00 | (2006.01) | ||
| C07J 1/0081 | (2013.01) | ||
| C07J 1/0085 | (2013.01) | ||
| C07J 9/00 | (2006.01) | ||
| C07J 7/002 | (2013.01) | ||
| C07J 1/00 | (2006.01) | ||
| C07J 43/00 | (2006.01) | ||
| C07J 9/00 | (2013.01) | ||
| C07J 41/00 | (2006.01) | ||
| C07J 17/00 | (2013.01) | ||
| A61K 31/565 | (2006.01) | ||
| C07J 41/0011 | (2013.01) | ||
| A61K 31/57 | (2006.01) | ||
| C07J 41/005 | (2013.01) | ||
| A61P 5/00 | (2006.01) | ||
| C07J 41/0066 | (2013.01) | ||
| A61P 25/08 | (2006.01) | ||
| C07J 41/0094 | (2013.01) | ||
| A61P 25/18 | (2006.01) | ||
| C07J 43/003 | (2013.01) | ||
| C07J 41/0005 | (2013.01) | ||
| A61P 25/20 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 25/20 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61K 31/58 | (2006.01) | ||
| A61P 25/18 | (2018.01) | ||
| A61K 31/575 | (2006.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61P 25/08 | (2018.01) |
| (11) | Patento numeris | 3481845 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17743136.8 |
| Europos patento paraiškos padavimo data | 2017-07-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/041600 |
| Data | 2017-07-11 |
| (87) | Numeris | WO 2018/013613 |
| Data | 2018-01-18 |
| (30) | Numeris | Data | Šalis |
| 201662360813 P | 2016-07-11 | US | |
| 201662360847 P | 2016-07-11 | US | |
| 201662424083 P | 2016-11-18 | US |
| (72) |
ROBICHAUD, Albert, J. , US
MARTINEZ BOTELLA, Gabriel , US
HARRISON, Boyd, L. , US
SALITURO, Francesco, G. , US
GRIFFIN, Andrew , CA
BLANCO-PILLADO, Maria, Jesus , US
|
| (73) |
Sage Therapeutics, Inc. ,
215 First Street, Cambridge, MA 02142,
US
|
| (54) | C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE |
| C17, C20, AND C21 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE |